Nuvation Bio Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Nuvation Bio Inc.
Former names: Panacea Acquisition Corp
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Delaware
Headquarters city: New York
Headquarters state / province: New York
Headquarters country: United States
Fiscal year end: December
Ticker symbol: NUVB
Primary stock exchange: NYSE

Identifiers

SEC CIK: 0001811063
EIN: 85-0862255

Board of directors

Follow this board

Daniel G. Welch · Director
Since 2023
David Hung · Director · PRESIDENT AND CEO
Since 2023
Junyuan Jerry Wang · Director · CEO, ANHEART THERAPEUTICS LTD.
Since 2024
Kathryn E. Falberg · Director
Since 2023
Kim D. Blickenstaff · Director
Since 2023
Oleg Nodelman · Director
Since 2023
Robert B. Bazemore · Director
Since 2023
Robert Mashal · Director
Since 2024
W. Anthony Vernon · Director
Since 2023
Xiangmin Cui · Director
Since 2024

Chief executives

Junyuan Jerry Wang · CEO, ANHEART THERAPEUTICS LTD.

Since April 2024

David Hung · President and CEO

Until April 2024 · Former

Director election results

Annual meeting of May 21, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

7 of this board's directors also sit on 13 other boards. 11 are in the same sector.

Shared director Other board Same sector

NovoCure Limited Same sector
via David Hung and W. Anthony Vernon
Akari Therapeutics plc Same sector
via Robert B. Bazemore
Aktis Oncology Inc. Same sector
via Oleg Nodelman
AnaptysBio Inc. Same sector
via Oleg Nodelman
Arcus Biosciences Inc. Same sector
via Kathryn E. Falberg
Ardelyx Inc. Same sector
via Robert B. Bazemore
McCormick & Company Incorporated
via W. Anthony Vernon
Prothena Corporation plc Same sector
via Daniel G. Welch
Structure Therapeutics Inc. Same sector
via Daniel G. Welch
Tandem Diabetes Care Inc. Same sector
via Kim D. Blickenstaff
The Trade Desk Inc.
via Kathryn E. Falberg
Ultragenyx Pharmaceutical Inc. Same sector
via Daniel G. Welch
Zymeworks Inc. Same sector
via Oleg Nodelman

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $118,250; 1 purchase by 1 insider
Sold, last 12 months: $9,179,901; 16 sales by 6 insiders

Date	Insider	Transaction	Shares	Price	Value
Aug 19, 2026	Hattersley Gary Officer (CHIEF SCIENTIFIC OFFICER)	Option exercise	+100,000	$1.87	$187,000
Aug 19, 2026	Hattersley Gary Officer (CHIEF SCIENTIFIC OFFICER)	Open-market sale	−100,000	$7.09	$709,000
Jul 15, 2026	Sauvage Philippe Officer (Chief Financial Officer)	Option exercise	+39,999	$2.17	$86,798
Jul 15, 2026	Sauvage Philippe Officer (Chief Financial Officer)	Option exercise	+1	$1.97	$2
Jun 23, 2026	Markel Stacy Officer (CHIEF PEOPLE OFFICER)	Option exercise	+90,380	$1.87	$169,011
Jun 23, 2026	Wentworth Kerry Officer (CHIEF REGULATORY OFFICER)	Option exercise	+63,000	$2.93	$184,590
Jun 23, 2026	Sauvage Philippe Officer (Chief Financial Officer)	Option exercise	+47,668	$2.17	$103,440
Jun 23, 2026	Markel Stacy Officer (CHIEF PEOPLE OFFICER)	Option exercise	+34,620	$1.74	$60,239
Jun 23, 2026	Wentworth Kerry Officer (CHIEF REGULATORY OFFICER)	Open-market sale	−63,000	$6.02	$379,260
Jun 23, 2026	Sauvage Philippe Officer (Chief Financial Officer)	Open-market sale	−47,668	$6.01	$286,485
Jun 23, 2026	Markel Stacy Officer (CHIEF PEOPLE OFFICER)	Open-market sale	−125,000	$6.03	$753,750
Jun 9, 2026	Robert Mashal Director	Open-market purchase	+25,000	$4.73	$118,250
Apr 17, 2026	Wentworth Kerry Officer (CHIEF REGULATORY OFFICER)	Option exercise	+36,750	$2.93	$107,678
Apr 17, 2026	Liu Dongfang Officer (CHIEF MEDICAL OFFICER)	Option exercise	+50,000	$1.94	$97,000
Apr 17, 2026	Wentworth Kerry Officer (CHIEF REGULATORY OFFICER)	Open-market sale	−36,750	$5.01	$184,118

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Nuvation Bio Inc.

Who is the CEO of Nuvation Bio Inc.?

Junyuan Jerry Wang has been Nuvation Bio Inc.'s CEO, ANHEART THERAPEUTICS LTD. since April 2024.

How many directors are on Nuvation Bio Inc.'s board?

Nuvation Bio Inc.'s board has 10 directors: Daniel G. Welch, David Hung, Junyuan Jerry Wang, Kathryn E. Falberg, Kim D. Blickenstaff, Oleg Nodelman, Robert B. Bazemore, Robert Mashal, W. Anthony Vernon and Xiangmin Cui.

Are Nuvation Bio Inc. insiders buying or selling shares?

Over the last 12 months, Nuvation Bio Inc. insiders bought $118,250 of shares in 1 purchase and sold $9.2 million of shares in 16 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Nuvation Bio Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="nuvation-bio-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.